The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113
Bupropion: a review of its mechanism of antidepressant activity.
Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., Golden, R. N., Martin, P., Potter, W. Z., & Richelson, E. (1995) · PubMed · Cited by 680
Artigas, F., Romero, L., de Montigny, C., & Blier, P. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10037-0 · Cited by 655
Hyttel, J. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80179-6 · Cited by 584
Self-citationIncreased Serotonin2 and β-Adrenergic Receptor Binding in the Frontal Cortices of Suicide Victims
Mann, J. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100048007 · Cited by 547
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 24×
“Overview of Methods Used for Determination of Monoamine Reuptake Inhibitory Potencies and Receptor Binding Affinities Target Ligand Tissuea or cell line Reference(s) Reuptake inhibition 5-HT 3H-5-HT Brain synapto- Hyttel, 1982, 1994 somes Cortical synapto- Muth et al., 1986; Eison et somes al., 1990 Hypothalamus Asche…”
BackgroundInfluentialSelf-citationMuth, E. A., Haskins, J. T., Moyer, J. A., Husbands, G. E. M., Nielsen, S. T., & Sigg, E. B. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90769-0 · Cited by 374
Brown, A. S., & Gershon, S. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245227 · Cited by 357
(1996) · PubMed · Cited by 328
Hrdina, P. D., Demeter, E., Vu, T. B., Sótónyi, P., & Palkovits, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91015-k · Cited by 327
The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
Hyttel, J., B�ges�, K. P., Perregaard, J., & S�nchez, C. (1992) · Journal of Neural Transmission · doi:10.1007/bf01244820 · Cited by 323
Self-citationA review of the metabolism and pharmacokinetics of paroxetine in man
Kaye, C. M., Haddock, R. E., Langley, P. F., Mellows, G., Tasker, T. C. G., Zussman, B. D., & Greb, W. H. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07176.x · Cited by 268
Koe, B. K., Weissman, A., Welch, W. M., & Browne, R. G. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21773-6 · Cited by 257
Muth, E. A., Moyer, J. A., Haskins, J. T., Andree, T. H., & Husbands, G. E. M. (1991) · Drug Development Research · doi:10.1002/ddr.430230210 · Cited by 212
Caccia, S., Cappi, M., Fracasso, C., & Garattini, S. (1990) · Psychopharmacology · doi:10.1007/bf02244004 · Cited by 207
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
Pälvimäki, E. P., Majasuo, H., Laakso, A., Kuoppamäki, M., Syvälahti, E., Roth, B. L., & Hietala, J. (1996) · Psychopharmacology · doi:10.1007/bf02246453 · Cited by 197
Fluoxetine: clinical pharmacology and physiologic disposition.
Lemberger, L., Bergstrom, R. F., Wolen, R. L., Farid, N. A., Enas, G. G., & Aronoff, G. R. (1985) · PubMed · Cited by 196
Nefazodone: preclinical pharmacology of a new antidepressant.
As, E., Eison, M. S., Torrente, J. R., Rn, W., & Yocca, F. D. (1990) · PubMed · Cited by 179
Hyttel, J., Over�, K. F., & Arnt, J. (1984) · Psychopharmacology · doi:10.1007/bf00427416 · Cited by 164
Self-citationMetabolic disposition of14C-venlafaxine in mouse, rat, dog, rhesus monkey and man
Howell, S. R., Husbands, G. E. M., Scatina, J., & Sisenwine, S. F. (1993) · Xenobiotica · doi:10.3109/00498259309057023 · Cited by 139
Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.
Iyer, R. N., & Bradberry, C. W. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12836-x · Cited by 131
Studies of bupropion's mechanism of antidepressant activity.
Ferris, R. M., Cooper, B. R., & Maxwell, R. A. (1983) · PubMed · Cited by 129
Moreau, J., Bös, M., Jenck, F., Martin, J. R., Mortas, P., & Wichmann, J. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)00015-6 · Cited by 123
Effect of antidepressants on striatal and accumbens extracellular dopamine levels
Ichikawa, J., & Meltzer, H. Y. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00264-l · Cited by 122
Metabolism and kinetics of bupropion.
Dh, S. (1983) · PubMed · Cited by 121
Clinical implications of the pharmacology of sertraline
WARRINGTON, S. J. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199112002-00004 · Cited by 119
Review of the animal pharmacology and pharmacokinetics of fluvoxamine.
Claassen, V. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02125.x · Cited by 114
Kinetics of citalopram in man; plasma levels in patients
Overø, K. F. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80181-4 · Cited by 113
Third‐generation antidepressants
Pinder, R. M., & Wieringa, J. H. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130304 · Cited by 108
Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors
Buckholtz, N. S., Zhou, D., & Freedman, D. X. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90342-6 · Cited by 108
Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
Dp, T., Carter, R. B., As, E., Mullins, U. L., Smith, H. L., Torrente, J. R., Rn, W., & Yocca, F. D. (1995) · PubMed · Cited by 108
Haddock, R. E., Johnson, A. M., Langley, P. F., Nelson, D. R., Pope, J., Thomas, D. R., & Woods, F. R. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07163.x · Cited by 95
Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo
Fuller, R. W. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90100-4 · Cited by 93
Brain β-adrenoceptor binding sites in antidepressant-free depressed suicide victims
Paermentier, F. D., Cheetham, S. C., Crompton, M. R., Katona, C., & Horton, R. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)91321-7 · Cited by 88
Rapid cycling depression in adolescence: A case treated with family therapy and carbamazepine
Spurkland, I., & Vandvik, I. H. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01300.x · Cited by 87
Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
Mayol, R. F., Cole, C. A., LUKE, G. M., Colson, K. L., & Kerns, E. H. (1994) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08374-6 · Cited by 81
Pharmacological significance of the species differences in bupropion metabolism
Welch, R. M., Lai, A. A., & Schroeder, D. H. (1987) · Xenobiotica · doi:10.3109/00498258709043939 · Cited by 81
Antidepressant Profile of Bupropion and three Metabolites in Mice
Martin, P., Massol, J., Colin, J. N., Lacomblez, L., & Puech, A. J. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014505 · Cited by 71
Fluvoxamine maleate: metabolism in man
Overmars, H., Scherpenisse, P., & Post, L. C. (1983) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188757 · Cited by 69
Age Related Decrease in the Density of Dopamine D1 and D2 Receptors in Corpus Striatum of Rats
Hyttel, J. (1987) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1987.tb01789.x · Cited by 69
Self-citationHalper, J. P., Brown, R. P., Sweeney, J. A., Kocsis, J. H., Peters, A., & MANN, J. D. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800270053006 · Cited by 67
Effects of antidepressant drugs on histamine-H1 receptors in the brain
Hall, H., & Ögren, S. O. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90494-6 · Cited by 63
Pharmacokinetic Optimisation of Therapy with Newer Antidepressants
Goodnick, P. J. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00005 · Cited by 58
Sprouse, J. S. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00112-q · Cited by 57
Posner, J., Bye, A., Dean, K., Peck, A. W., & Whiteman, P. D. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00547376 · Cited by 53
Eison, A. S., Eison, M. S., Yocca, F. D., et al. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90400-1 · Cited by 48
Hypothesis linking the noradrenergic and dopaminergic systems in depression
Weiss, J. M., Demetrikopoulos, M. K., West, C. H. K., & Bonsall, R. W. (1995) · Depression · doi:10.1002/depr.3050030503 · Cited by 42
Borsini, F. (1994) · Pharmacological Research · doi:10.1016/1043-6618(94)80082-0 · Cited by 34
Comparative pharmacology of dothiepin, its metabolites, and other antidepressant drugs
Heal, D. J., Cheetham, S. C., Martin, K. F., Browning, J., Luscombe, G. P., & Buckett, R. (1992) · Drug Development Research · doi:10.1002/ddr.430270205 · Cited by 19
Nefazodone and venlafaxine: two new agents for the treatment of depression.
Rj, G. (1995) · PubMed · Cited by 4
Cited by
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., LaVasseur, B. I., Barton, D. L., Novotny, P. J., Dakhil, S. R., Rodger, K., Rummans, T. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03403-6 · Cited by 737
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
Gillman, P. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707253 · Cited by 694
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Metadata
- Authors
- Sánchez, C., & Hyttel, J.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 1999-08
- Volume
- 19
- Issue
- 4
- Pages
- 467-489
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- OpenAlex
- W2193494830
- Cited by
- 429
- References
- 50
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.